Small Cell Lung Cancer News and Research

RSS
Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. Small cell lung cancer is an aggressive (fast-growing) cancer that can spread to other parts of the body. The cancer cells look small and oval-shaped when looked at under a microscope.
First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

First Phase II study of immunotherapy combined with curative radiotherapy for unresectable locally advanced NSCLC

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Consolidation PD-(L)1 inhibition following concurrent chemoradiation for unresectable stage III NSCLC improves survival

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Study reveals the intertumoral heterogeneity of METex14 skipping positive NSCLCs

Study reveals the intertumoral heterogeneity of METex14 skipping positive NSCLCs

Sub lobar surgery found to be non-inferior to lobectomy for patients with small-sized peripheral NSCLC

Sub lobar surgery found to be non-inferior to lobectomy for patients with small-sized peripheral NSCLC

Increased use of stereotactic body radiation therapy for NSCLC patients can reduce treatment disparities

Increased use of stereotactic body radiation therapy for NSCLC patients can reduce treatment disparities

New recommendations on how to determine eligibility criteria for lung cancer clinical trials

New recommendations on how to determine eligibility criteria for lung cancer clinical trials

Researchers report genomic profiling from more than 110,000 tumors

Researchers report genomic profiling from more than 110,000 tumors

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

Damon Runyon Cancer Research Foundation names five new Damon Runyon Clinical Investigators

Innovative strategy for treating non-small cell lung cancer when radiotherapy fails

Innovative strategy for treating non-small cell lung cancer when radiotherapy fails

Study provides better understanding of how therapeutic resistance develops in lung cancer

Study provides better understanding of how therapeutic resistance develops in lung cancer

Nanoparticles can be triggered to release anti-cancer microRNA using an alternating magnetic field

Nanoparticles can be triggered to release anti-cancer microRNA using an alternating magnetic field

New $5.3 million NIH grant will support researchers into understanding lung cancer recurrence

New $5.3 million NIH grant will support researchers into understanding lung cancer recurrence

MD Anderson announces collaborative alliance with Turning Point Therapeutics to advance new treatment options for cancer patients

MD Anderson announces collaborative alliance with Turning Point Therapeutics to advance new treatment options for cancer patients

New report estimates cancer prevalence in the U.S. and provides survivorship statistics

New report estimates cancer prevalence in the U.S. and provides survivorship statistics

Area-level education and income linked with patients' lung cancer stage at the time of diagnosis

Area-level education and income linked with patients' lung cancer stage at the time of diagnosis